These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 31274262)
1. Circulating visfatin levels in the second and third trimester of pregnancies with gestational diabetes: a systematic review. Pace NP; Bonello A; Roshan MH; Vassallo J Minerva Ginecol; 2019 Aug; 71(4):329-343. PubMed ID: 31274262 [TBL] [Abstract][Full Text] [Related]
2. Association between circulating visfatin and gestational diabetes mellitus: a systematic review and meta-analysis. Zhang W; Zhao D; Meng Z; Wang H; Zhao K; Feng X; Li Y; Dun A; Jin X; Hou H Acta Diabetol; 2018 Nov; 55(11):1113-1120. PubMed ID: 29992461 [TBL] [Abstract][Full Text] [Related]
3. Hepatokine levels during the first or early second trimester of pregnancy and the subsequent risk of gestational diabetes mellitus: a systematic review and meta-analysis. Cai Z; Yang Y; Zhang J Biomarkers; 2021 Sep; 26(6):517-531. PubMed ID: 34082623 [TBL] [Abstract][Full Text] [Related]
4. Relationship of maternal serum resistin and visfatin levels with gestational diabetes mellitus. Karatas A; Tunçay Işikkent N; Ozlü T; Demirin H Gynecol Endocrinol; 2014 May; 30(5):355-8. PubMed ID: 24512558 [TBL] [Abstract][Full Text] [Related]
5. Visfatin level and gestational diabetes mellitus: a systematic review and meta-analysis. Jiang YK; Deng HY; Qiao ZY; Gong FX Arch Physiol Biochem; 2021 Oct; 127(5):468-478. PubMed ID: 33476191 [TBL] [Abstract][Full Text] [Related]
6. Visfatin concentration is decreased in women with gestational diabetes mellitus in the third trimester. Akturk M; Altinova AE; Mert I; Buyukkagnici U; Sargin A; Arslan M; Danisman N J Endocrinol Invest; 2008 Jul; 31(7):610-3. PubMed ID: 18787378 [TBL] [Abstract][Full Text] [Related]
7. Increased visfatin concentrations in women with gestational diabetes mellitus. Krzyzanowska K; Krugluger W; Mittermayer F; Rahman R; Haider D; Shnawa N; Schernthaner G Clin Sci (Lond); 2006 May; 110(5):605-9. PubMed ID: 16489932 [TBL] [Abstract][Full Text] [Related]
8. Adipokine levels during the first or early second trimester of pregnancy and subsequent risk of gestational diabetes mellitus: A systematic review. Bao W; Baecker A; Song Y; Kiely M; Liu S; Zhang C Metabolism; 2015 Jun; 64(6):756-64. PubMed ID: 25749468 [TBL] [Abstract][Full Text] [Related]
9. Elevated serum levels of visfatin in gestational diabetes: a comparative study across various degrees of glucose tolerance. Lewandowski KC; Stojanovic N; Press M; Tuck SM; Szosland K; Bienkiewicz M; Vatish M; Lewinski A; Prelevic GM; Randeva HS Diabetologia; 2007 May; 50(5):1033-7. PubMed ID: 17334748 [TBL] [Abstract][Full Text] [Related]
11. Maternal lipid levels during pregnancy and gestational diabetes: a systematic review and meta-analysis. Ryckman KK; Spracklen CN; Smith CJ; Robinson JG; Saftlas AF BJOG; 2015 Apr; 122(5):643-51. PubMed ID: 25612005 [TBL] [Abstract][Full Text] [Related]
12. First trimesters Pregnancy-Associated Plasma Protein-A levels value to Predict Gestational diabetes Mellitus: A systematic review and meta-analysis of the literature. Talasaz ZH; Sadeghi R; Askari F; Dadgar S; Vatanchi A Taiwan J Obstet Gynecol; 2018 Apr; 57(2):181-189. PubMed ID: 29673658 [TBL] [Abstract][Full Text] [Related]
13. [Role of visfatin in the pathogenesis of gestational diabetes mellitus and its relationship with insulin resistance]. Huo Y; Liu S; Feng J; Li H; Fan Y; Jin Y; Li L Zhonghua Fu Chan Ke Za Zhi; 2014 Aug; 49(8):584-7. PubMed ID: 25354858 [TBL] [Abstract][Full Text] [Related]
14. Placental expressions and serum levels of adiponectin, visfatin, and omentin in GDM. Souvannavong-Vilivong X; Sitticharoon C; Klinjampa R; Keadkraichaiwat I; Sripong C; Chatree S; Sririwichitchai R; Lertbunnaphong T Acta Diabetol; 2019 Oct; 56(10):1121-1131. PubMed ID: 31076892 [TBL] [Abstract][Full Text] [Related]
15. Leptin, resistin and visfatin as useful predictors of gestational diabetes mellitus. Bawah AT; Seini MM; Abaka-Yawason A; Alidu H; Nanga S Lipids Health Dis; 2019 Dec; 18(1):221. PubMed ID: 31836012 [TBL] [Abstract][Full Text] [Related]
16. Increased Peripheral Blood Visfatin Concentrations May Be a Risk Marker of Coronary Artery Disease: A Meta-Analysis of Observational Studies. Yu F; Li J; Huang Q; Cai H Angiology; 2018 Oct; 69(9):825-834. PubMed ID: 29706084 [TBL] [Abstract][Full Text] [Related]
17. Gestational diabetes is associated with high energy and saturated fat intakes and with low plasma visfatin and adiponectin levels independent of prepregnancy BMI. Park S; Kim MY; Baik SH; Woo JT; Kwon YJ; Daily JW; Park YM; Yang JH; Kim SH Eur J Clin Nutr; 2013 Feb; 67(2):196-201. PubMed ID: 23385969 [TBL] [Abstract][Full Text] [Related]
18. Plasma visfatin levels in pregnant women with normal glucose tolerance, gestational diabetes and pre-gestational diabetes mellitus. Coskun A; Ozkaya M; Kiran G; Kilinc M; Arikan DC J Matern Fetal Neonatal Med; 2010 Sep; 23(9):1014-8. PubMed ID: 20059442 [TBL] [Abstract][Full Text] [Related]
19. Decreased plasma visfatin concentrations in women with gestational diabetes mellitus. Chan TF; Chen YL; Lee CH; Chou FH; Wu LC; Jong SB; Tsai EM J Soc Gynecol Investig; 2006 Jul; 13(5):364-7. PubMed ID: 16814166 [TBL] [Abstract][Full Text] [Related]
20. Serum levels of visfatin and possible interaction with iron parameters in gestational diabetes mellitus. Kaygusuz I; Gumus II; Yılmaz S; Simavlı S; Uysal S; Derbent AU; Gözdemir E; Kafalı H Gynecol Obstet Invest; 2013; 75(3):203-9. PubMed ID: 23548246 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]